Combining these results, the authors believed that stigmasterol induced apoptosis and protective autophagy in gastric cancer cells while inhibiting the Akt/mTOR signaling pathway, and they thought stigmasterol was likely to become a potential anticancer agent in future gastric cancer treatment. The gene discussed is MTOR; the disease is gastric cancer.